IP Library › Assignment 055642/0372
Patent Assignment
Reel/Frame 055642/0372

Assignment of Assignor's Interest

Recorded: 2021-03-18 Pages: 7
Assignor
FIBROCELL SCIENCE, INC.
Executed: 2021-03-12
Assignee
CASTLE CREEK BIOSCIENCES, LLC
405 EAGLEVIEW BOULEVARD, EXTON, PENNSYLVANIA, 19341
Covered Properties (29)
Use of Autologous Dermal Fibroblasts for the Repair of Skin and Soft Tissue Defects
Patent: 5,591,444 →
Application: 08/508,773 →
Augmentation and Repair of Vocal Cord Tissue Defects.
Patent: 7,412,978 →
Application: 09/634,038 →
Augmentation and Repair of Vocal Cord Tissue Defects
Patent: 8,261,749 →
Application: 12/194,316 →
Publication: US 2008/0311089
Method of Using Autologous Fibroblasts to Promote Healing of Wounds and Fistulas
Patent: 7,846,465 →
Application: 09/980,150 →
Method of Using Autologous Fibroblasts to Promote Healing of Wounds and Fistulas
Patent: 7,115,274 →
Application: 11/040,419 →
Publication: US 2005/0147596
Compositions for Regenerating Tissue That Has Degenerated, and Methods for Using Such Compositions
Application: 09/083,618 →
Compositions for Regenerating Tissue That Has Degenerated, and Methods for Using Such Compositions
Application: 09/316,245 →
Compositions for Regenerating Tissue That Has Deteriorated, and Methods for Using Such Compositions
Patent: 6,432,710 →
Application: 09/678,047 →
Compositions for Regenerating Tissue That Has Deteriorated, and Methods for Using Such Compositions
Patent: 6,878,383 →
Application: 10/167,173 →
Publication: US 2003/0228286
Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof
Application: 60/823,871 →
Methods for Culturing Minimally-Passaged Fibroblasts and Uses Thereof
Patent: 8,728,819 →
Application: 12/438,932 →
Publication: US 2010/0297088
Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
Patent: 9,902,937 →
Application: 14/280,957 →
Publication: US 2014/0335057
Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
Application: 15/869,613 →
Publication: US 2018/0346878
Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
Application: 17/126,859 →
Publication: US 2021/0180021
Methods for Culturing Dermal Cells for Treatment of Skin Injuries Such as Burns
Application: 60/882,274 →
Methods for Culturing Dermal Cells for Treatment of Skin Injuries Such as Burns
Application: 12/521,262 →
Publication: US 2010/0303770
Methods for Culturing Dermal Cells for Treatment of Skin Injuries Such as Burns
Application: 15/158,385 →
Publication: US 2016/0340651
Dosage Unit Formulations of Autologous Dermal Fibroblasts
Patent: 8,529,883 →
Application: 12/776,163 →
Publication: US 2011/0274665
Dosage Unit Formulations of Autologous Dermal Fibroblasts
Application: 13/941,265 →
Publication: US 2013/0295061
Topical Dermal Formulations
Application: 61/377,803 →
Topical Dermal Formulations
Application: 61/421,516 →
Topical Dermal Formulations
Application: 13/220,163 →
Publication: US 2012/0219634
Topical Dermal Formulations
Application: 14/100,871 →
Publication: US 2014/0099383
Treatment of Vocal Cords with Autologous Dermal Fibroblast Formulation
Application: 61/393,247 →
Treatment of Vocal Cords with Autologous Dermal Fibroblast Formulation
Patent: 8,765,121 →
Application: 13/879,606 →
Publication: US 2013/0224160
Treatment of Vocal Cords With Autologous Dermal Fibroblast Formulation
Patent: 9,415,075 →
Application: 14/295,155 →
Publication: US 2014/0348801
Treatment Of Vocal Cords With Autologous Dermal Fibroblast Formulation
Application: 15/235,767 →
Publication: US 2017/0035811
Treatment Of Vocal Cords With Autologous Dermal Fibroblast Formulation
Application: 16/124,690 →
Publication: US 2019/0151368
Treatment Of Vocal Cords With Autologous Dermal Fibroblast Formulation
Application: 17/110,653 →
Publication: US 2021/0299183
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 4, 1996
From: BOSS, WILLIAM K., JR.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 007983/0110 →
Assignment of Assignor's Interest Aug 10, 1998
From: BOSS, WILLIAM K., JR.; MARKO, OLGA
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 009416/0617 →
Assignment of Assignor's Interest Nov 4, 1999
From: MARKO, OLGA; BOSS, WILLIAM K., JR.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 010357/0156 →
Assignment of Assignor's Interest Feb 12, 2001
From: MARKO, OLGA; BOSS, WILLIAM K., JR.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 011515/0160 →
Assignment of Assignor's Interest May 21, 2003
From: REVAZOVA, ELENA
To: KELLER, GREGORY S.
Reel/Frame 014088/0052 →
Assignment of Assignor's Interest Jul 2, 2007
From: MARKO, OLGA; BOSS, WILLIAM K. JR.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 019501/0984 →
Assignment of Assignor's Interest Jul 2, 2007
From: REVAZOVA, ELENA
To: KELLER, GREGORY S.
Reel/Frame 019501/0979 →
Assignment of Assignor's Interest Jul 2, 2007
From: KELLER, GREGORY S.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 019501/0975 →
Assignment of Assignor's Interest Jul 2, 2010
From: MASLOWSKI, JOHN M.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 024633/0167 →
Assignment of Assignor's Interest Nov 16, 2010
From: MASLOWSKI, JOHN
To: FIBROCELL SCIENCE, INC.
Reel/Frame 025368/0069 →
Assignment of Assignor's Interest Mar 4, 2011
From: MASLOWSKI, JOHN M.; DALY, DECLAN
To: FIBROCELL SCIENCE, INC.
Reel/Frame 025900/0382 →
Change of Name Jul 15, 2011
From: ISOLAGEN, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 026601/0287 →
Change of Name Aug 5, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026711/0564 →
Assignment of Assignor's Interest Aug 5, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN, INC.
Reel/Frame 026709/0354 →
Change of Name Aug 5, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026708/0428 →
Change of Name Aug 24, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026803/0103 →
Corrective Assignment to Correct the Error in Assignee Name Which Is Isolagen Technologies, Inc.; Now D/B/a Fibrocell Technologies, Inc. Previously Recorded on Reel 026709 Frame 0354. Assignor(S) Hereby Confirms the Entire Right, Title and Interest in the Inventions Was Transferred by Gregory S. Keller to Assignee. Aug 24, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 026803/0167 →
Change of Name Oct 3, 2011
From: ISOLOGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 027008/0939 →
Assignment of Assignor's Interest Nov 14, 2011
From: MASLOWSKI, JOHN M.; DALY, DECLAN
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 027221/0937 →
Assignment of Assignor's Interest May 9, 2012
From: LINDNER, MARIE A.; THOMAS, MYRNA F.
To: ISOLAGEN, INC.
Reel/Frame 028183/0142 →
Assignment of Assignor's Interest Jun 20, 2012
From: MASLOWSKI, JOHN
To: FIBROCELL SCIENCE, INC.
Reel/Frame 028413/0334 →
Assignment of Assignor's Interest Jun 20, 2012
From: MASLOWSKI, JOHN
To: FIBROCELL SCIENCE, INC.
Reel/Frame 028413/0098 →
Assignment of Assignor's Interest Nov 6, 2012
From: FIBROCELL SCIENCE, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 029247/0660 →
Assignment of Assignor's Interest Mar 26, 2013
From: FIBROCELL SCIENCE, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 030082/0988 →
Assignment of Assignor's Interest Jul 18, 2013
From: MASLOWSKI, JOHN M.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 030829/0631 →